Granahan Investment Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FAM
FLAM
Granahan Investment Management's ATRC Position: Q4 2022 in Review
Granahan Investment Management sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 181,602 shares — an estimated $7.1M sold.
Granahan Investment Management first reported a position in ATRC in Q2 2014 and held it in 17 quarters. The position peaked at $13.2M in Q2 2015. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.
- Granahan Investment Management reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
- Granahan Investment Management sold 181,602 AtriCure shares in Q4 2022, an estimated $7.1M.
- Granahan Investment Management first reported a position in AtriCure in Q2 2014 and held it in 17 quarters.
- Granahan Investment Management's AtriCure position peaked at $13.2M in Q2 2015.
- 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.
Based on Granahan Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.